Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
STRATA Skin Sciences
SSKN
STRATA Skin Sciences
Regulatory Hurdles And Device Risks Will Constrain Operations Yet Stabilize
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
20 Aug 25
Updated
20 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$4.00
56.3% undervalued
intrinsic discount
20 Aug
US$1.75
Loading
1Y
-41.8%
7D
-2.2%
Author's Valuation
US$4.0
56.3% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$4.0
56.3% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-34m
37m
2014
2017
2020
2023
2025
2026
2028
Revenue US$37.1m
Earnings US$4.6m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
6.53%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
12.32%
Calculation
US$4.61m
Earnings '28
x
4.91x
PE Ratio '28
=
US$22.67m
Market Cap '28
US$22.67m
Market Cap '28
/
4.17m
No. shares '28
=
US$5.44
Share Price '28
US$5.44
Share Price '28
Discounted to 2025 @ 12.32% p.a.
=
US$3.84
Fair Value '25
